All Insights
Showing 181 - 192 of 2042
ESG – Environmental, Social and Governance
ESG Knowledge Update | February 2026
Welcome to our Osborne Clarke ESG Knowledge Update, which offers a round-up of legal, regulatory and market news
Digital Regulation
EDPB and EDPS release much-anticipated joint opinion on the EU Digital Omnibus
Both EU data protection bodies criticise the definition of personal data and highlight areas for further specification and improvement
Competition, antitrust and trade
The UK CMA updates its merger remedies guidance
The regulator may be more open to behavioural remedies, but only where it is satisfied they are effective and proportionate
Competition, antitrust and trade
Will there be a more streamlined UK merger control process?
The CMA's procedural overhaul offers merging parties more influence over timing and remedies, but whether it will shorten reviews remains
Competition, antitrust and trade
What does the Getty Images/Shutterstock decision tell business about how the CMA approaches mergers in the UK?
Competition and Markets Authority rejects Getty/Shutterstock remedies, despite focus on growth
Regulatory and compliance
Future Foods Takeaway | Brussels’ beef with plant-based food names
The alternative foods sector awaits with uncertainty for an outcome from the next round of EU talks on meat names
Competition, antitrust and trade
UK government consults on major reforms to competition processes
The government's growth agenda underlies a set of sweeping and probably controversial proposals
Life Sciences and Healthcare
EU device package envisages more support for 'orphan' and breakthrough products and flexible access in crises
In-house exemptions, 'orphan grandfathering', 'sandboxes' and crisis derogations aim to balance unmet needs with safety
Life Sciences and Healthcare
Draft EU medtech revisions adjust importer and distributor roles to support supply chain resilience
Digital obligations, leaner repackaging rules and new shortage reporting tools may evolve supply chain responsibilities
Life Sciences and Healthcare
Data-driven digital health businesses challenged with balancing AI advances and tighter regulation in 2026
Hyper-personalisation, data interoperability and AI are among 2025's fast-evolving areas to continue to watch this year
Life Sciences and Healthcare
EU MDR and IVDR poised to remain main framework for medical AI in draft AI interface reforms
Lex specialis treatment, integrated notified body reviews and clarified duties are designed to limit overlapping regulation of medical AI
Advertising and marketing regulation
Marketinglaw: January 2026
Welcome to the latest edition of Marketinglaw
